Our Mission

Access Vascular was founded to reinvent venous access.

Our company was founded to solve the significant yet unmet needs in venous access. After shadowing physicians and learning about the challenge that thrombosis presents to venous access, our founders set off to develop a new, superior material to the polyurethane used in conventional venous catheters. We plan to expand our material platform to potentially provide long-term infection protection and minimize vessel trauma during catheter insertion.

In 2018, we secured FDA clearance on our first product, a peripherally inserted central catheter (PICC) which was found to be effective in reducing thrombosis accumulation*. That’s just the beginning: we are developing a comprehensive suite of venous access devices, including peripheral venous catheters, dialysis catheter and ports.

We are a privately held company based in Bedford, MA. Our headquarters consists of a 7,100 square foot facility that includes state-of-the-art laboratory and manufacturing spaces. We employ approximately 20 employees and have begun commercial sales of our first product.

*Reduction of thrombosis accumulation was evaluated using in vitro and in vivo models.

Quality Policy

Access Vascular is committed to providing our customers with the highest quality intravascular products that meet or exceed expectations. Access Vascular commits to comply with the necessary requirements and regulations through the regular maintenance of an effective quality system and seeks to continuously improve its products.

Management Team

JAmes Biggins

Founder, President and CEO

After shadowing physicians at a Boston Hospital and witnessing complications first-hand, James was compelled to design a better venous catheter. Before founding Access Vascular, James held product development, engineering, and clinical affairs roles at Ocular Therapeutix, Boston Scientific, and Medtronic, bringing over a dozen products from concept to commercialization.

Michael Bassett

Chief Scientific Officer

An R&D executive with more than 20 years of hydrogel experience, Michael most recently served as Director of Development at Ocular Therapeutix where he co-invented and developed a drug delivery platform for commercialization. He also held product development, program manager and manufacturing positions with Confluent Surgical (Covidien), Anika Therapeutics, Spherics and Focal Inc.

Brian Hanley

Senior Director of Operations

Brian has 15 years of medical device engineering and program management experience, including tenures at CSA Medical, Hologic Inc, and Boston Scientific. He is experienced in the design, development, and manufacturing of catheters, surgical devices, disposable accessories and integrated systems.

Rohit Joshi

Director of Sales and Marketing

Rohit has eight years of experience helping medical device companies establish strategy, achieve customer adoption, and execute on business development opportunities. Before joining Access Vascular, he spent several years in Deloitte Consulting’s life sciences group and most recently led marketing and business development for a medical device startup.

Board of Directors

  • James Biggins: Founder, President, and CEO, Access Vascular

  • J.J. Pellegrino: CFO, LeMaitre Medical

  • Brent Ratz: Co-founder and CEO, CardiAQ Valve Technologies

  • Paul Sabin: Principal, Fikst

Scientific and Technical Advisors

  • Dr. Gary Ansel: System Medical Chief of Vascular Services, Ohio Health Heart

  • Nadine Nakazawa: Vascular Access Specialist, Stanford Health Care

  • Dr. Kenneth Rosenfeld: Section Head of Vascular Medicine, MGH

  • Dr. Jeremy Schiller: Interventional Radiologist, Mt. Auburn Hospital